Table 4.
Gender | Change in % points baseline – endline (mean) |
Range | Largest change in % points between two time points (mean) |
Range | Proportionate change baseline to endline (mean) |
Range | Largest change as a proportion of baseline (mean) | Range | |
---|---|---|---|---|---|---|---|---|---|
Physical IPV | |||||||||
All studies* | Female | 6.70 | 0.9,27.8 | 8.06 | 1.0,27.8 | 0.162 | 0.024,0.37 | 0.201 | 0.024,0.37 |
Male | 8.36 | 1.7,25.0 | 9.02 | 1.7,25.0 | 0.203 | 0.076, 0.336 | 0.216 | 0.076, 0.336 | |
All studies with no active controls @ | Female | 3.18 | 0.9, 5.7 | 4.77 | 1,10.8 | 0.127 | 0.024, 0.289 | 0.173 | 0.024, 0.368 |
Male | 4.20 | 1.7, 6.8 | 5.03 | 1.7,9.7 | 0.17 | 0.077, 0.298 | 0.186 | 0.077,0.298 | |
Cohorts with no active controls *** | Female | 3.10 | 0.9, 5.7 | 5.23 | 2.2, 10.8 | 0.078 | 0.027, 0.113 | 0.12 | 0.066, 0.180 |
Male | 6.60 | 6.4, 6.8 | 8.25 | 6.8,9.7 | 0.213 | 0.127, 0.298 | 0.245 | 0.192, 0.298 | |
Repeat cross-sectional*** | Female | 3.27 | 1, 4.4 | 4.30 | 1.0, 7.5 | 0.176 | 0.024, 0.288 | 0.227 | 0.024, 0.368 |
Male | 1.80 | 1.7, 1.9 | 1.80 | 1.7, 1.9 | 0.127 | 0.076, 0.178 | 0.127 | 0.076, 0.178 | |
Sexual IPV | |||||||||
All studies$ | Female | 5.60 | 0.5, 23.1 | 6.55 | 0.9, 23.1 | 0.134 | 0.013, 0.332 | 0.175 | 0.024, 0.339 |
Male | 3.32 | 0.6,5.0 | 6.04 | 0.6, 16.8 | 0.14 | 0.036, 0.238 | 0.229 | 0.034, 0.553 | |
All studies with no active controls ** | Female | 2.10 | 0.5, 5.2 | 3.24 | 0.9, 8.1 | 0.094 | 0.013, 0.172 | 0.144 | 0.024, 0.339 |
Male | 2.9 | 0.6, 4.0 | 6.3 | 0.6, 16.8 | 0.146 | 0.036, 0.238 | 0.258 | 0.034, 0.553 | |
Cohorts with no active controls # | Female | 2.85 | 0.5, 5.2 | 2.1 | 0.9, 3.3 | 0.093 | 0.013, 0.172 | 0.067 | 0.024, 0.109 |
Male | 3.6 | 3.2, 4.0 | 10.4 | 4.0, 16.8 | 0.155 | 0.105, 0.204 | 0.378 | 0.204, 0.553 | |
Repeat cross-sectional *** | Female | 1.6 | 0.9, 2.2 | 4 | 1.7, 8.1 | 0.095 | 0.038, 0.200 | 0.137 | 0.048, 0.339 |
Male | 2.2 | 0.6, 3.8 | 2.2 | 0.6, 3.8 | 0.137 | 0.036, 0.238 | 0.196 | 0.036, 0.238 | |
Severe IPV | |||||||||
All studies* | Female | 7.99 | 0.9, 36.5 | 9.91 | 1.2, 36.5 | 0.189 | 0.022, 0.552 | 0.240 | 0.024, 0.552 |
Male | 10.08 | 1.7, 34.7 | 10.66 | 1.7, 34.7 | 0.228 | 0.086, 0.529 | 0.240 | 0.086, 0.529 | |
All studies with no active controls ** | Female | 3.23 | 0.9, 6.6 | 5.48 | 1.2, 11.1 | 0.129 | 0.022, 0.167 | 0.189 | 0.024, 0.375 |
Male | 3.93 | 1.7, 5.9 | 4.65 | 1.7, 8.8 | 0.152 | 0.086, 0.254 | 0.168 | 0.086, 0.254 | |
Cohorts with no active controls *** | Female | 3 | 0.9, 5.3 | 5.43 | 2.4, 11.1 | 0.094 | 0.022, 0.167 | 0.141 | 0.058, 0.198 |
Male | 5.8 | 5.7, 5.9 | 7.25 | 5.7, 8.8 | 0.191 | 0.127, 0.254 | 0.222 | 0.189, 0.254 | |
Repeat cross-sectional*** | Female | 3.47 | 1.2, 6.6 | 5.53 | 1.2, 8.8 | 0.163 | 0.024, 0.375 | 0.236 | 0.024, 0.375 |
Male | 2.05 | 1.7, 2.4 | 2.05 | 1.7, 2.4 | 0.114 | 0.086, 0.141 | 0.114 | 0.086, 0.141 |
* 12 datasets **9 datasets ***5 datasets $ 11 datasets # 4 datasets @ 10 datasets.